Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A large-cohort, longitudinal study determines pre-cancer disease routes across different cancer types

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence, type distribution, and risk factors for oral HPV in Danish renal transplant recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Yifan Wang
  • Andrea J Bernhardy
  • Cristina Cruz
  • John J Krais
  • Joseph Nacson
  • Emmanuelle Nicolas
  • Suraj Peri
  • Hanneke van der Gulden
  • Ingrid van der Heijden
  • Shane W O'Brien
  • Yong Zhang
  • Maribel I Harrell
  • Shawn F Johnson
  • Francisco J Candido Dos Reis
  • Paul D P Pharoah
  • Beth Karlan
  • Charlie Gourley
  • Diether Lambrechts
  • Georgia Chenevix-Trench
  • Håkan Olsson
  • Javier J Benitez
  • Mark H Greene
  • Martin Gore
  • Robert Nussbaum
  • Siegal Sadetzki
  • Simon A Gayther
  • Susanne K Kjaer
  • Alan D D'Andrea
  • Geoffrey I Shapiro
  • David L Wiest
  • Denise C Connolly
  • Mary B Daly
  • Elizabeth M Swisher
  • Peter Bouwman
  • Jos Jonkers
  • Judith Balmaña
  • Violeta Serra
  • Neil Johnson
  • kConFab Investigators
View graph of relations

Breast and ovarian cancer patients harboring BRCA1/2 germline mutations have clinically benefitted from therapy with PARP inhibitor (PARPi) or platinum compounds, but acquired resistance limits clinical impact. In this study, we investigated the impact of mutations on BRCA1 isoform expression and therapeutic response. Cancer cell lines and tumors harboring mutations in exon 11 of BRCA1 express a BRCA1-Δ11q splice variant lacking the majority of exon 11. The introduction of frameshift mutations to exon 11 resulted in nonsense-mediated mRNA decay of full-length, but not the BRCA1-Δ11q isoform. CRISPR/Cas9 gene editing as well as overexpression experiments revealed that the BRCA1-Δ11q protein was capable of promoting partial PARPi and cisplatin resistance relative to full-length BRCA1, both in vitro and in vivo Furthermore, spliceosome inhibitors reduced BRCA1-Δ11q levels and sensitized cells carrying exon 11 mutations to PARPi treatment. Taken together, our results provided evidence that cancer cells employ a strategy to remove deleterious germline BRCA1 mutations through alternative mRNA splicing, giving rise to isoforms that retain residual activity and contribute to therapeutic resistance. Cancer Res; 76(9); 2778-90. ©2016 AACR.

Original languageEnglish
JournalCancer Research
Volume76
Issue number9
Pages (from-to)2778-90
Number of pages13
ISSN0008-5472
DOIs
Publication statusPublished - 1 May 2016

    Research areas

  • Journal Article

ID: 49569260